“Clinical Efficacy or Tildrakizumab in Patients With Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S4, https://doi.org/10.25251/skin.2.supp.4.